Browsing Tag
Inc.
196 posts
Will mobile-first AI give Medallia the edge in real-time customer feedback battles?
Medallia brings real-time AI to frontline workers with mobile-first upgrades—transforming how enterprises act on customer feedback. Discover what’s new.
Half of platinum-resistant ovarian cancer patients respond to Raludotatug deruxtecan in REJOICE-Ovarian01 trial
Find out how Raludotatug deruxtecan achieved a 50 % response rate in platinum-resistant ovarian cancer and what it means for future ADC therapies.
Will Navan’s IPO be the next travel-tech breakout or just another high-burn unicorn testing public markets?
Navan targets $6.45 billion valuation in upcoming Nasdaq listing, but faces regulatory delays, valuation compression, and profitability pressures
Will Washington blink first? Trump dangles a health-care deal if Democrats end the shutdown
Trump says he’ll discuss ACA subsidies with Democrats—but only after reopening government. Find out what’s at stake for consumers and insurers.
Amazon Grocery launch sparks fresh battle with Costco’s Kirkland and Walmart’s Great Value
Amazon rolls out a new private label brand to challenge Costco’s Kirkland and Walmart’s Great Value. Find out how this move could reshape grocery retail.
Are AI-discovered vaccines the next big frontier in pharma?
AI-discovered vaccines are moving from hype to reality. See how Evaxion, BioNTech, DIOSynVax and Baseimmune are reshaping discovery—and why big pharma is buying.
Winrevair slashes early PAH worsening by 76% in phase 3 Hyperion, but can it reset first-year care?
Winrevair reduced PAH clinical worsening by 76% in phase 3 Hyperion. Learn how Merck’s results could reset first-year treatment guidelines today.
Why Merck’s MSD is paying up to $600m for Evaxion’s undisclosed vaccine candidate EVX-B3
MSD licenses Evaxion’s AI-discovered vaccine EVX-B3 with $7.5M upfront and up to $592M in milestones—why this risky biotech bet could redefine vaccines.
Why Advanced Drainage Systems just dropped $1bn on NDS—and why investors think this could reshape water infrastructure
Advanced Drainage Systems’ $1B buy of Norma Group’s NDS water unit could reshape stormwater and irrigation markets. See how this deal impacts stocks and strategy.
Strive and Semler Scientific plan all-stock Bitcoin bet that unites 10,900 BTC under one roof
Strive (ASST) will buy Semler Scientific (SMLR) in a 210%-premium, all-stock Bitcoin-treasury merger. Find out how this deal could reshape corporate crypto today.